Be in the know. 5 key reads for Tuesday…

  1. Top Baird Health Care and Biotech Picks Have Massive Upside Potential (24/7 Wall Street)
  2. Amgen Shows Price Is Still Right for Blockbuster Drug Deals (Wall Street Journal)
  3. China says it hopes U.S. can create conditions for trade talks (Reuters)
  4. Why Jefferies Top Value Picks Include Some of the Biggest US Banks (24/7 Wall Street)
  5. This index is making a hidden bet on biotechs (MarketWatch)

DOW + (8 S&P 500 top weights) Earnings Estimates/Revisions

In the spreadsheet above I have tracked the earnings estimates for the DOW 30 PLUS 8 of the S&P 500 top 30 weights [that are not either included in the DOW 30 or in the top 30 weights of the Nasdaq]. The 8 companies are at the bottom of the spreadsheet under the heading “EXTRA”. The purpose of this is so we have up to date EPS earnings/revisions for the top 30 weighted stocks in the DOW, S&P500, Russell 2000, and Nasdaq. Continue reading “DOW + (8 S&P 500 top weights) Earnings Estimates/Revisions”

Be in the know. 10 key reads for Sunday…

1. When Taking Risks Is the Best Strategy (Wall Street Journal)
2. Brexit Bargain Shoppers: Investors Snap Up Peppa Pig, Beer and Jet Technology (Wall Street Journal)
3. Not All Energy Stocks Are Depressed (Wall Street Journal)
4. Boeing 737 Max’s Certification Flight Likely to Occur in October (Bloomberg)
5. Michael Burry (from “The Big Short”) Urges GameStop to Buy Back $238 Million of Stock with Cash on Hand (Business Wire)
6. Value Stocks Haven’t Traded This Low Since the Dot-Com Bubble (Validea)
7. Stocks Haven’t Seen The Top Yet? (Tumblr)
8. ECRI Weekly Leading Index Update (Advisor Perspectives)
9. Finance Friday With Mary, Volume 3: Snack-Sized Questions (NPR Planet Money)
10. How to Become a Better Forecaster of the Future (Podcast) (Bloomberg Odd Lots)